Arquimea Group
Avenida Premios Nobel, 53, Torrejón de Ardoz, Madrid, 28850, Spain
Overview
ARQUIMEA develops electronic, microelectronic, and electro-mechanic systems and components, including smart actuators and mechanisms, sensing systems, integrated circuits (IC) and robotic parts. ARQUIMEA’s products and technologies are suitable for those markets and sectors demanding innovation, quality, high performance and reliability, such as Aerospace, Defence & Security, Industry, Automotive, Medical or Agroindustry. ARQUIMEA is committed to offer its clients products adapted to their needs and expert technical advice, with the goal of collaborating in the progress and development of the society in which we live. Production processes at ARQUIMEA are developed following the strictest and most exhaustive international quality regulations.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 7
Sector focus
- Apps
- Electronics
- Software
Investment portfolio
- Vaxdyn
Participated · Equity · Mar 2021
Vaxdyn develops multi‑pathogen vaccine candidates aimed at preventing infections caused by antibiotic‑resistant bacteria. Headquartered in Seville, Spain, the company works with an international network of collaborators to target high‑risk populations (chronic lung, liver, kidney disease, immunocompromised patients, nursing‑home and hospital settings). Its vision is to create specific immunity in these groups and to reduce antibiotic use worldwide following a One‑Health approach. Recent financing activity includes share acquisitions by Bionova Capital and Arquimea Group (each valued at €300,000 in two tranches) and a €100,000 capital increase from the Mind the Gap Program. Vaxdyn also benefits from CARB‑X support: up to $7.3 million in non‑dilutive, milestone‑based funding to advance its lead vaccine candidate through a first‑in‑human study. Strategic investors are positioned to contribute sector expertise and cross‑sector technological support to the company’s vaccine development efforts.